125 related articles for article (PubMed ID: 27626217)
1. Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission.
Sun Y; Shen H; Xu T; Yang Z; Qiu H; Sun A; Chen S; Wu D; Xu Y
Leuk Res; 2016 Oct; 49():102-7. PubMed ID: 27626217
[TBL] [Abstract][Full Text] [Related]
2. [Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen].
Sun Y; Xu Y; Wu D; Shen H; Yang Z; Qiu H; Chen S; Sun A
Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):1025-30. PubMed ID: 26759106
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients.
Chen M; Zeng Z; Li X; Qin W; Cai X; Chen S; Lu X
Int J Lab Hematol; 2023 Dec; 45(6):899-907. PubMed ID: 37519024
[TBL] [Abstract][Full Text] [Related]
4. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
[TBL] [Abstract][Full Text] [Related]
5. [Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy].
Wang LL; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):845-850. PubMed ID: 38049337
[No Abstract] [Full Text] [Related]
6. Identification of Cell Type-Specific Effects of
Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
[TBL] [Abstract][Full Text] [Related]
7. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
[TBL] [Abstract][Full Text] [Related]
8. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.
Hirsch P; Lambert J; Bucci M; Deswarte C; Boudry A; Lambert J; Fenwarth L; Micol JB; Terré C; Celli-Lebras K; Thomas X; Dombret H; Duployez N; Preudhomme C; Itzykson R; Delhommeau F
Blood Cancer J; 2024 Jun; 14(1):97. PubMed ID: 38871702
[TBL] [Abstract][Full Text] [Related]
9. Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia.
Gale RE; Lamb K; Allen C; El-Sharkawi D; Stowe C; Jenkinson S; Tinsley S; Dickson G; Burnett AK; Hills RK; Linch DC
J Clin Oncol; 2015 Jun; 33(18):2072-83. PubMed ID: 25964253
[TBL] [Abstract][Full Text] [Related]
10. Effect of
Tabatabaei T; Rezvany MR; Ghasemi B; Vafaei F; Zadeh MK; Zaker F; Salmaninejad A
Biomed Res Int; 2024; 2024():9625043. PubMed ID: 38807916
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission.
Lai X; Xiao J; Wang T; Hou C; Chen J; Wu D; Xu Y
Leuk Lymphoma; 2024 Mar; 65(3):363-371. PubMed ID: 37990829
[TBL] [Abstract][Full Text] [Related]
13. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy.
Itzykson R; Fournier E; Berthon C; Röllig C; Braun T; Marceau-Renaut A; Pautas C; Nibourel O; Lemasle E; Micol JB; Adès L; Lebon D; Malfuson JV; Gastaud L; Goursaud L; Raffoux E; Wattebled KJ; Rousselot P; Thomas X; Chantepie S; Cluzeau T; Serve H; Boissel N; Terré C; Celli-Lebras K; Preudhomme C; Thiede C; Dombret H; Gardin C; Duployez N
Blood; 2021 Aug; 138(7):507-519. PubMed ID: 34410352
[TBL] [Abstract][Full Text] [Related]
14. CD7-positive leukemic blasts with
Bai Y; Sun X; Li M; Niu X; Cao W; Niu J; Xiao X; Chen Y; Sun K
Front Oncol; 2024; 14():1342998. PubMed ID: 38577341
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient.
García-Álvarez M; Yeguas A; Jiménez C; Medina-Herrera A; González-Calle V; Hernández-Ruano M; Maldonado R; Aires I; Casquero C; Sánchez-Villares I; Balanzategui A; Sarasquete ME; Alcoceba M; Vidriales MB; González-Díaz M; García-Sanz R; Chillón MC
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255173
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of
Lin ME; Hou HA; Tsai CH; Wu SJ; Kuo YY; Tseng MH; Liu MC; Liu CW; Chou WC; Chen CY; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Lin CT; Tien HF
Clin Epigenetics; 2018; 10():42. PubMed ID: 29619119
[TBL] [Abstract][Full Text] [Related]
17. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway.
Palam LR; Ramdas B; Pickerell K; Pasupuleti SK; Kanumuri R; Cesarano A; Szymanski M; Selman B; Dave UP; Sandusky G; Perna F; Paczesny S; Kapur R
JCI Insight; 2023 May; 8(9):. PubMed ID: 36976647
[TBL] [Abstract][Full Text] [Related]
18. Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Tanaka T; Morita K; Loghavi S; Wang F; Furudate K; Sasaki Y; Little L; Gumbs C; Matthews J; Daver N; Pemmaraju N; DiNardo CD; Sasaki K; Yilmaz M; Kadia TM; Ravandi F; Konopleva MY; Kantarjian HM; Champlin RE; Al-Atrash G; Garcia-Manero G; Wang SA; Futreal PA; Takahashi K
Blood; 2021 Nov; 138(18):1733-1739. PubMed ID: 34115096
[TBL] [Abstract][Full Text] [Related]
19. Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.
Hu Z; Yang Y; Li J; Hu Z
Hematology; 2024 Dec; 29(1):2346965. PubMed ID: 38687637
[TBL] [Abstract][Full Text] [Related]
20. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT; Nicolet D; Kelly BJ; Mrózek K; LaHaye S; Miller KE; Wijeratne S; Wheeler G; Kohlschmidt J; Blachly JS; Mims AS; Walker CJ; Oakes CC; Orwick S; Boateng I; Buss J; Heyrosa A; Desai H; Carroll AJ; Blum W; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Stone RM; Paskett ED; Byrd JC; Mardis ER; Eisfeld AK
Blood Adv; 2022 Oct; 6(19):5570-5581. PubMed ID: 35788257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]